{"database": "lobbying", "table": "lobbying_activities", "rows": [[2102545, "74fad7c9-b64b-40ff-bf1d-01f2005585b0", "Q1", "RED+BLUE STRATEGIES", 400693064, "PEW CHARITABLE TRUSTS", 2018, "first_quarter", "MMM", "H.R. 1625/PL 115-141 - Consolidated Appropriations Act of 2018 - Issues related to policies regarding antibiotic resistance, compounding, policies surrounding access to prescription medications and policies to combat the opioid crisis in the United States. \n\nH.R. 1301/PL 115-124 - Continuing Resolution of 2018 - Issues related access and affordability of prescription medications in the United States, treatment of biosimilars and generics in public and private insurance and policies to combat the opioid crisis in the United States. \n\nCMS regulations related to Medicare Part D and promulgation of laws related to curbing substance use disorder among Medicare beneficiaries. \n\nIssues related to health information technology, unique device identifiers on Medicare claims forms, and other critical policies to promote device safety.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2018-04-06T15:25:52.453000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2102545"], "units": {}, "query_ms": 0.36663212813436985, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}